Skip to main content
Premium Trial:

Request an Annual Quote

Response Genetics Delisted from Nasdaq

NEW YORK (GenomeWeb) – Response Genetics today disclosed that its stock has been delisted from the Nasdaq and will now trade on the Over-the-Counter Bulletin Board.

In late December, the company said that its shares were facing delisting for failing to meet the Nasdaq's $1 minimum bid price requirement. The company had previously been notified that it also did not meet the exchange's minimum $2.5 million in stockholders’ equity requirement

Over the past 52 weeks, Response Genetics's shares have traded as high as $.94 and as low as $.18 apiece. They finished last week at $.27.